{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/30/3319382/0/en/Press-Release-Sanofi-s-Nexviazyme-met-all-primary-and-secondary-endpoints-in-infantile-onset-Pompe-disease-phase-3-study.html", "message": "News view counter 822343 successfully enlarged"}